Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 120

1.

Red blood cell distribution width-to-platelet ratio as a disease activity-associated factor in systemic lupus erythematosus.

Xie S, Chen X.

Medicine (Baltimore). 2018 Sep;97(39):e12342. doi: 10.1097/MD.0000000000012342.

2.

Power in numbers.

Vinet E, Chakravarty EF, Clowse MEB.

Rheumatology (Oxford). 2018 Jul 1;57(suppl_5):v40-v47. doi: 10.1093/rheumatology/key111.

PMID:
30137590
3.

The prevention, screening and treatment of congenital heart block from neonatal lupus: a survey of provider practices.

Clowse MEB, Eudy AM, Kiernan E, Williams MR, Bermas B, Chakravarty E, Sammaritano LR, Chambers CD, Buyon J.

Rheumatology (Oxford). 2018 Jul 1;57(suppl_5):v9-v17. doi: 10.1093/rheumatology/key141.

PMID:
30137589
4.

Molecular mechanisms of glucocorticoid resistance in systemic lupus erythematosus: A review.

Gao H, Wang Q, Yu X, Liu J, Bai S, Feng J, Wu B.

Life Sci. 2018 Sep 15;209:383-387. doi: 10.1016/j.lfs.2018.08.038. Epub 2018 Aug 17. Review.

PMID:
30125579
5.

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial.

Wallace DJ, Furie RA, Tanaka Y, Kalunian KC, Mosca M, Petri MA, Dörner T, Cardiel MH, Bruce IN, Gomez E, Carmack T, DeLozier AM, Janes JM, Linnik MD, de Bono S, Silk ME, Hoffman RW.

Lancet. 2018 Jul 21;392(10143):222-231. doi: 10.1016/S0140-6736(18)31363-1. Erratum in: Lancet. 2018 Aug 11;392(10146):476.

PMID:
30043749
6.

Baricitinib for systemic lupus erythematosus.

Mucke J, Schneider M.

Lancet. 2018 Jul 21;392(10143):190-192. doi: 10.1016/S0140-6736(18)31574-5. No abstract available.

PMID:
30043741
7.

Vimentin as antigenic target in autoimmunity: A comprehensive review.

Musaelyan A, Lapin S, Nazarov V, Tkachenko O, Gilburd B, Mazing A, Mikhailova L, Shoenfeld Y.

Autoimmun Rev. 2018 Sep;17(9):926-934. doi: 10.1016/j.autrev.2018.04.004. Epub 2018 Jul 17. Review.

PMID:
30009963
8.

Antibodies targeting circulating protective molecules in lupus nephritis: Interest as serological biomarkers.

Dumestre-Pérard C, Clavarino G, Colliard S, Cesbron JY, Thielens NM.

Autoimmun Rev. 2018 Sep;17(9):890-899. doi: 10.1016/j.autrev.2018.03.013. Epub 2018 Jul 29. Review.

PMID:
30009962
9.

Classification of primary antiphospholipid syndrome as systemic lupus erythematosus: Analysis of a cohort of 214 patients.

Paule R, Morel N, Le Guern V, Fredi M, Coutte L, Belhocine M, Mouthon L, le Jeunne C, Chauvin A, Piette JC, Costedoat-Chalumeau N.

Autoimmun Rev. 2018 Sep;17(9):866-872. doi: 10.1016/j.autrev.2018.03.011. Epub 2018 Jul 10. Review.

PMID:
30005859
10.

Drug-induced lupus: Traditional and new concepts.

Vaglio A, Grayson PC, Fenaroli P, Gianfreda D, Boccaletti V, Ghiggeri GM, Moroni G.

Autoimmun Rev. 2018 Sep;17(9):912-918. doi: 10.1016/j.autrev.2018.03.016. Epub 2018 Jul 10. Review.

PMID:
30005854
11.

Depression and anxiety in systemic lupus erythematosus: The crosstalk between immunological, clinical, and psychosocial factors.

Figueiredo-Braga M, Cornaby C, Cortez A, Bernardes M, Terroso G, Figueiredo M, Mesquita CDS, Costa L, Poole BD.

Medicine (Baltimore). 2018 Jul;97(28):e11376. doi: 10.1097/MD.0000000000011376.

12.

Association between PPP2CA polymorphisms and clinical features in southwest Chinese systemic lupus erythematosus patients.

Zhang J, Meng Y, Wu H, Wu Y, Yang B, Wang L.

Medicine (Baltimore). 2018 Jul;97(27):e11451. doi: 10.1097/MD.0000000000011451.

13.

Retrospective analysis of the risk of hemorrhage associated with moderate and severe thrombocytopenia of 173 patients with systemic lupus erythematosus.

Li J, Pan Z, Liu H, Ding F, Shu Q, Li X.

Medicine (Baltimore). 2018 Jul;97(27):e11356. doi: 10.1097/MD.0000000000011356.

14.
15.

Immunosuppressive treatment for proliferative lupus nephritis.

Tunnicliffe DJ, Palmer SC, Henderson L, Masson P, Craig JC, Tong A, Singh-Grewal D, Flanc RS, Roberts MA, Webster AC, Strippoli GF.

Cochrane Database Syst Rev. 2018 Jun 29;6:CD002922. doi: 10.1002/14651858.CD002922.pub4. Review.

PMID:
29957821
16.

Rapid detection of urinary soluble intercellular adhesion molecule-1 for determination of lupus nephritis activity.

Wang Y, Tao Y, Liu Y, Zhao Y, Song C, Zhou B, Wang T, Gao L, Zhang L, Hu H.

Medicine (Baltimore). 2018 Jun;97(26):e11287. doi: 10.1097/MD.0000000000011287.

17.

Diagnostic approach to neuropsychiatric lupus erythematosus: what should we do?

Zardi EM, Giorgi C, Zardi DM.

Postgrad Med. 2018 Aug;130(6):536-547. doi: 10.1080/00325481.2018.1492309. Epub 2018 Jul 9. Review.

PMID:
29940795
18.

Comment on: The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults.

Ruiz-Irastorza G, Ugarte A, Ruiz-Arruza I, Erdozain JG, Gonzalez-Echavarri C, Soto A.

Rheumatology (Oxford). 2018 Aug 1;57(8):1501-1502. doi: 10.1093/rheumatology/key168. No abstract available.

PMID:
29893930
19.

Comment on: The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: reply.

Gordon C, Amissah-Arthur MB, Gayed M, Brown S, Bruce IN, D'Cruz D, Empson B, Griffiths B, Jayne D, Khamashta M, Lightstone L, Norton P, Norton Y, Schreiber K, Isenberg D; British Society for Rheumatology Standards, Audit and Guidelines Working Group.

Rheumatology (Oxford). 2018 Aug 1;57(8):1502-1503. doi: 10.1093/rheumatology/key170. No abstract available.

PMID:
29893921
20.

The 2018 pipeline of targeted therapies under clinical development for Systemic Lupus Erythematosus: a systematic review of trials.

Felten R, Dervovic E, Chasset F, Gottenberg JE, Sibilia J, Scher F, Arnaud L.

Autoimmun Rev. 2018 Aug;17(8):781-790. doi: 10.1016/j.autrev.2018.02.011. Epub 2018 Jun 6. Review.

PMID:
29885544

Supplemental Content

Loading ...
Support Center